Deferasirox demonstrates a dose‐dependent reduction in liver iron concentration and consistent efficacy across subgroups of non‐transfusion‐dependent thalassemia patients-Reference-Cited by-同舟云学术

Deferasirox demonstrates a dose‐dependent reduction in liver iron concentration and consistent efficacy across subgroups of non‐transfusion‐dependent thalassemia patients

Published:2013-05-13 Issue:6 Volume:88 Page:503-506
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Taher Ali T.¹,Porter John B.²,Viprakasit Vip³,Kattamis Antonis⁴,Chuncharunee Suporn⁵,Sutcharitchan Pranee⁶,Siritanaratkul Noppadol³,Galanello Renzo⁷,Karakas Zeynep⁸,Lawniczek Tomasz⁹,Habr Dany¹⁰,Ros Jacqueline⁹,Zhang Yiyun¹⁰,Cappellini M. Domenica¹¹

Affiliation:

1. Hematology and Oncology, Department of Internal Medicine, American University of BeirutBeirut Lebanon

2. UCL Cancer Institute, Department of Haematology, University College LondonLondon United Kingdom

3. Department of Pediatrics and Internal MedicineSiriraj Hospital, Mahidol UniversityBangkok Thailand

4. First Department of PediatricsUniversity of AthensAthens Greece

5. Ramathibodi Hospital, Mahidol UniversityBangkok Thailand

6. Chulalongkorn University and King Chulalongkorn Memorial HospitalBangkok Thailand

7. Ospedale Regional MicrocitemieCagliari Italy

8. Istanbul University, Istanbul Medical FacultyIstanbul Turkey

9. Novartis Pharma AGBasel Switzerland

10. Novartis PharmaceuticalsEast Hanover New Jersey

11. Department of Internal Medicine, Università di Milano, Ca Granda Foundation IRCCSMilan Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.23445

Reference20 articles.

1. Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemia

2. Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

3. Beta-thalassemia

4. α-thalassaemia

5. Alpha and beta thalassemia;Muncie HL;Am Fam Physician,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease;American Journal of Hematology;2024-07-22

2. Αlpha-thalassemia: A practical overview;Blood Reviews;2024-03

3. An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results;American Journal of Hematology;2022-05-27

4. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias;British Journal of Haematology;2021-10-06

5. Effectiveness and Safety of Deferasirox in Thalassemia with Iron Overload: A Meta-Analysis;Acta Haematologica;2018-11-30